Lv4
564 积分 2025-01-20 加入
Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis
7天前
已完结
Coupling Met to Specific Pathways Results in Distinct Developmental Outcomes
7天前
已完结
A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers
9天前
已完结
First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer
9天前
已完结
Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib
9天前
已完结
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer
9天前
已完结
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study
9天前
已完结
Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis
12天前
已关闭
SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo
12天前
已完结
Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer
12天前
已完结
皖公网安备34019202002308
